Prevalence and prevention of cardiovascular disease and diabetes mellitus

详细信息    查看全文

• 作者：Pitchai Balakumar^a ; ^{pbala2006@gmail.com" class="auth_mail" title="E-mail the corresponding author} ; Khin Maung-U^b ; ¹ ; ^{Khin.U@fda.hhs.gov" class="auth_mail" title="E-mail the corresponding author} ; Gowraganahalli Jagadeesh^b ; ¹ ; ^{gowra.jagadeesh@fda.hhs.gov" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Noncommunicable diseases ; Cardiovascular risk factors ; Cardiovascular disease prevalence ; Diabetes mellitus ; Disease prevention
• 刊名：Pharmacological Research
• 出版年：2016
• 出版时间：November 2016
• 年：2016
• 卷：113
• 期：part_PA
• 页码：600-609
• 全文大小：825 K

文摘

Noncommunicable diseases (NCDs) have become important causes of mortality on a global scale. According to the report of World Health Organization (WHO), NCDs killed 38 million people (out of 56 million deaths that occurred worldwide) during 2012. Cardiovascular diseases accounted for most NCD deaths (17.5 million NCD deaths), followed by cancers (8.2 million NCD deaths), respiratory diseases (4.0 million NCD deaths) and diabetes mellitus (1.5 million NCD deaths). Globally, the leading cause of death is cardiovascular diseases; their prevalence is incessantly progressing in both developed and developing nations. Diabetic patients with insulin resistance are even at a greater risk of cardiovascular disease. Obesity, high cholesterol, hypertriglyceridemia and elevated blood pressure are mainly considered as major risk factors for diabetic patients afflicted with cardiovascular disease. The present review sheds light on the global incidence of cardiovascular disease and diabetes mellitus. Additionally, measures to be taken to reduce the global encumbrance of cardiovascular disease and diabetes mellitus are highlighted.